BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 33512477)

  • 1. The complex network of mTOR signalling in the heart.
    Sciarretta S; Forte M; Frati G; Sadoshima J
    Cardiovasc Res; 2022 Jan; 118(2):424-439. PubMed ID: 33512477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights Into the Role of mTOR Signaling in the Cardiovascular System.
    Sciarretta S; Forte M; Frati G; Sadoshima J
    Circ Res; 2018 Feb; 122(3):489-505. PubMed ID: 29420210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1.
    Ghomlaghi M; Yang G; Shin SY; James DE; Nguyen LK
    PLoS Comput Biol; 2021 Sep; 17(9):e1008513. PubMed ID: 34529665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.
    Völkers M; Konstandin MH; Doroudgar S; Toko H; Quijada P; Din S; Joyo A; Ornelas L; Samse K; Thuerauf DJ; Gude N; Glembotski CC; Sussman MA
    Circulation; 2013 Nov; 128(19):2132-44. PubMed ID: 24008870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic modeling of signal transduction by mTOR complexes in cancer.
    Dorvash M; Farahmandnia M; Mosaddeghi P; Farahmandnejad M; Saber H; Khorraminejad-Shirazi M; Azadi A; Tavassoly I
    J Theor Biol; 2019 Dec; 483():109992. PubMed ID: 31493485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
    Weinberg MA
    Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation.
    Ding X; Bloch W; Iden S; Rüegg MA; Hall MN; Leptin M; Partridge L; Eming SA
    Nat Commun; 2016 Oct; 7():13226. PubMed ID: 27807348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of mTOR Signaling after Brain Ischemia.
    Villa-González M; Martín-López G; Pérez-Álvarez MJ
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications.
    Yang L; Zhang Z; Wang D; Jiang Y; Liu Y
    Curr Drug Targets; 2022; 23(7):692-710. PubMed ID: 35021971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
    Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
    Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mTOR in normal and pathological conditions.
    Marques-Ramos A; Cervantes R
    Mol Cancer; 2023 Jul; 22(1):112. PubMed ID: 37454139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
    Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
    Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC1 and mTORC2 Complexes Regulate the Untargeted Metabolomics and Amino Acid Metabolites Profile through Mitochondrial Bioenergetic Functions in Pancreatic Beta Cells.
    Soliman GA; Abzalimov RR; He Y
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting mTORC1/2 with OSI-027 inhibits proliferation and migration of keloid keratinocytes.
    Chen J; Liu K; Liu Y; Wang X; Zhang Z
    Exp Dermatol; 2019 Mar; 28(3):270-275. PubMed ID: 30650200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
    Yoon MS
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mTORC1 and mTORC2 in Breast Cancer: Therapeutic Targeting of mTOR and Its Partners to Overcome Metastasis and Drug Resistance.
    Butt G; Shahwar D; Qureshi MZ; Attar R; Akram M; Birinci Y; Karatoprak GS; Gasparri ML; Farooqi AA
    Adv Exp Med Biol; 2019; 1152():283-292. PubMed ID: 31456190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTORC2: a multifaceted regulator of autophagy.
    Sun Y; Wang H; Qu T; Luo J; An P; Ren F; Luo Y; Li Y
    Cell Commun Signal; 2023 Jan; 21(1):4. PubMed ID: 36604720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growing knowledge of the mTOR signaling network.
    Huang K; Fingar DC
    Semin Cell Dev Biol; 2014 Dec; 36():79-90. PubMed ID: 25242279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and metabolic functions of mTORC1 and mTORC2.
    Szwed A; Kim E; Jacinto E
    Physiol Rev; 2021 Jul; 101(3):1371-1426. PubMed ID: 33599151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural mechanisms of the mTOR pathway.
    Linde-Garelli KY; Rogala KB
    Curr Opin Struct Biol; 2023 Oct; 82():102663. PubMed ID: 37572585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.